Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®

Study Overview
=================
Brief Summary
-----------------
This study aims to look at patient and physician satisfaction of long term Glabellar lines (GL) treatment with Dysport in a real life setting. It will also allow better understanding of what patients expect from the treatment, and the injection practices used by doctors.

Official Title
-----------------
An Assessment of Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®.

Conditions
-----------------
Glabellar Lines

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patient with moderate to severe GL naïve of any type of aesthetic treatment/procedure (invasive and non-invasive) for GL who provided written informed consent to take part. Patient who has prior to and independent of the study decided to undergo long term treatment of GL only (at least three cycles). Patient able to comply with the protocol (completion of web questionnaires). Patient whom physician intended to treat with Dysport independent of participation in the study. Exclusion Criteria: Patient already included in this study. Participation in an interventional trial within 30 days prior to study entry. Patient who is at risk in terms of precautions, warnings, and contraindication (follow local Summary of Product Characteristics (SmPC) of Dysport). Female patient who is pregnant, nursing or planning a pregnancy during the study. Hypersensitivity to Dysport® or to its excipients. Presence of infection at the proposed injection sites. Presence of myasthenia gravis, Eaton Lambert syndrome or amyotrophic lateral sclerosis.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To assess patient satisfaction regarding GL after three injection cycles of Dysport. | Assessed by patient auto questionnaire completion | Within 3 weeks ±7 days of visit 3 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To describe patient individual expectations. | Assessed by patient auto questionnaire completion | Within 3 weeks ±7 days of visit 1 and 2 | 
| To assess patient satisfaction after one and two injection cycles of Dysport. | Assessed by patient auto questionnaire completion | Within 3 weeks ±7 days of visit 1 and 2 | 
| To describe factors associated with patient satisfaction such as attractiveness, self-esteem, self-perceived age, desire to receive another injection. | Assessed by patient auto questionnaire completion | Within 3 weeks ±7 days of visit 1 and 2 | 
| To assess the GL severity (at rest and maximum frown) as per usual practice. | Physician assessment using GL severity scale | Baseline (visit 1) and visit 3 | 
| To assess physician satisfaction after one and three injection cycles of Dysport. | 5 point Likert scale | Visit 1 follow up visit and visit 3 follow up visit (if performed) | 
| To describe Dysport injection practices: muscles injected, total injected units, total volume injected, number of injection points and interval between injections. |  | From visit 1 until the end of the study |